Literature DB >> 30010746

Patients on levothyroxine replacement in the community: association between hypothyroidism symptoms, co-morbidities and their quality of life.

Ngiap Chuan Tan1,2, Rong Quan Chew3, Reena Chandhini Subramanian1, Usha Sankari1, Yi Ling Eileen Koh1, Li Wei Cho4.   

Abstract

INTRODUCTION: Patients may be symptomatic, resulting in lower quality of life (QOL), despite L-thyroxine (LT4) therapy for hypothyroidism or having normal thyroid function. We hypothesized that their clinical symptoms of hypothyroidism and co-morbidities were associated with QOL.
OBJECTIVE: The study aimed to determine the association between the hypothyroid-related symptoms of Asian patients on LT4 treatment, their co-morbidities and their QOL.
METHOD: A questionnaire survey was conducted from November 2015 to July 2016 on consecutive multi-ethnic Asian patients on LT4 treatment for their hypothyroidism in a public primary care clinic in Singapore. Data on their demography, clinical symptoms, morbidity status, QOL scores based on the EQ5D instrument and thyroid function tests were computed and analysed, including logistic regression analysis to identify factors associated with lower QOL.
RESULTS: Complete data of 226 Asian patients (79.0% women; 74.2% Chinese, 10.0% Malay, 13.1% Indian and 2.6% other minority groups; median age 57 years; 27.5% had previous thyroid surgery) were analysed. Their QOL was not associated with their socio-demographic profiles, clinical parameters and latest thyroid-stimulating hormone and free thyroxine levels. Patients reporting weight gain, dry or coarse skin, leg swelling, feeling weak and carpal tunnel syndrome had significantly lower QOL; 53.6% of them with any single symptom had lower QOL. More patients had lower QOL if they had two or more symptoms and multiple medical conditions.
CONCLUSION: In Asian patients with hypothyroidism, weight gain, feeling tired, feeling weak, having dry or coarse skin, leg swelling and increased number of co-morbidities and symptoms were significantly associated with poorer QOL.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Co-morbidities; deficiency; health care; primary hyperthyroidism; therapy; thyroid function test; thyroid-stimulating hormone

Mesh:

Substances:

Year:  2019        PMID: 30010746     DOI: 10.1093/fampra/cmy064

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  Weight Gain After Thyroidectomy: A Systematic Review and Meta-Analysis.

Authors:  Christine N Huynh; Janina V Pearce; Le Kang; Francesco S Celi
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

2.  Hypothyroid Symptoms in Levothyroxine-Treated Patients.

Authors:  Maisha Kelly Freeman; Georges A Adunlin; Candice Mercadel; Sara Danzi; Irwin Klein
Journal:  Innov Pharm       Date:  2019-10-09

Review 3.  Hypothyroidism and Depression: A Narrative Review.

Authors:  Surya P Nuguru; Sriker Rachakonda; Shravani Sripathi; Mashal I Khan; Naomi Patel; Roja T Meda
Journal:  Cureus       Date:  2022-08-20

4.  Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design.

Authors:  Ritu Madan; Francesco S Celi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

Review 5.  What Is the Quality of Life in Patients Treated with Levothyroxine for Hypothyroidism and How Are We Measuring It? A Critical, Narrative Review.

Authors:  Françoise Borson-Chazot; Jean-Louis Terra; Bernard Goichot; Philippe Caron
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.